Dr. Jean Hurteau on Diagnosing Ovarian Clear Cell Carcinoma

Jean Hurteau, MD
Published: Monday, Mar 21, 2016



Jean Hurteau, MD, professor, Division of Gynecologic Oncology at NorthShore University Health System, discusses the difficulties of diagnosing ovarian clear cell carcinoma. Hurteau says data for the diagnosis of the carcinoma is older, and is not relevant to contemporary diagnoses due to the fact that there were more mixed tumors previously than there are now.
 
Hurteau says these tumors are being further defined by their immunocytochemical properties and how much of the tumor is comprised of being clear cell. He adds that there is more information available now than previously, which lends itself to further defining these tumors.
 


Jean Hurteau, MD, professor, Division of Gynecologic Oncology at NorthShore University Health System, discusses the difficulties of diagnosing ovarian clear cell carcinoma. Hurteau says data for the diagnosis of the carcinoma is older, and is not relevant to contemporary diagnoses due to the fact that there were more mixed tumors previously than there are now.
 
Hurteau says these tumors are being further defined by their immunocytochemical properties and how much of the tumor is comprised of being clear cell. He adds that there is more information available now than previously, which lends itself to further defining these tumors.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x